Home » Topics » BioWorld Science

BioWorld Science
RSS

Neurocrine Biosciences highlights positive Q3 developments

Nov. 5, 2001

New multidrug resistance modulator designed at Penn State

Nov. 5, 2001

Combination of GTI-2040 and capecitabine examined in renal cell carcinoma

Nov. 5, 2001

Favorable sixth phase III safety review of VaxGen's AIDS vaccine

Nov. 5, 2001

Next-generation oncolytic virus from Onyx selectively propagates in tumor cells

Nov. 5, 2001

Inhaled iseganan safe in cystic fibrosis patients

Nov. 5, 2001

Completion of rolling BLA submission for Erbitux

Nov. 5, 2001

Year-end completion of recruitment expected in renal cell carcinoma trial of Neovastat

Nov. 5, 2001

ChemGenex investigates molecular targets of Ceflatonin

Nov. 5, 2001

Xolair BLA amendment will be submitted in the fourth quarter of 2002

Nov. 5, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...